SE459899B - Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi - Google Patents

Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi

Info

Publication number
SE459899B
SE459899B SE8105561A SE8105561A SE459899B SE 459899 B SE459899 B SE 459899B SE 8105561 A SE8105561 A SE 8105561A SE 8105561 A SE8105561 A SE 8105561A SE 459899 B SE459899 B SE 459899B
Authority
SE
Sweden
Prior art keywords
pak
ketoglutarate
pharmaceutical composition
administration
pyridoxine
Prior art date
Application number
SE8105561A
Other languages
English (en)
Swedish (sv)
Other versions
SE8105561L (sv
Inventor
F Fici
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of SE8105561L publication Critical patent/SE8105561L/
Publication of SE459899B publication Critical patent/SE459899B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8105561A 1980-09-22 1981-09-21 Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi SE459899B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24827/80A IT1141070B (it) 1980-09-22 1980-09-22 Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia

Publications (2)

Publication Number Publication Date
SE8105561L SE8105561L (sv) 1982-03-23
SE459899B true SE459899B (sv) 1989-08-21

Family

ID=11214855

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8105561A SE459899B (sv) 1980-09-22 1981-09-21 Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi

Country Status (12)

Country Link
US (1) US4361570A (it)
JP (1) JPS5782316A (it)
BE (1) BE890454A (it)
CA (1) CA1177408A (it)
CH (1) CH655009A5 (it)
DE (1) DE3137125A1 (it)
FR (1) FR2490493B1 (it)
GB (1) GB2084018A (it)
IT (1) IT1141070B (it)
NL (1) NL8104357A (it)
SE (1) SE459899B (it)
ZA (1) ZA816242B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (en) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
EP1196171A2 (en) 1999-07-13 2002-04-17 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
EP1210117A2 (en) * 1999-08-24 2002-06-05 Medicure International Inc. Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
DE60133323T2 (de) 2000-02-29 2009-03-05 Medicure International Inc. Cardioprotektive Phosphonate
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
EP1817288A4 (en) 2004-10-28 2009-08-26 Medicure Int Inc DUAL ANTIPLÄTTCHEN / ANTIKOAGULANS PYRIDOXINANALOGE
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
WO2009073944A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. USE OF PYRIDOXINE α-HYDROXYISOCAPROATE TO REDUCE METABOLIC ACIDOSIS AND AMMONIA ACCUMULATION
US20090156648A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
US10278327B2 (en) 2014-05-09 2019-05-07 Shakespeare Company, Llc Trimmer head for use with line and blades
US20210369750A1 (en) * 2018-10-24 2021-12-02 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6453M (it) * 1967-06-13 1968-11-12
ES360566A1 (es) * 1968-11-22 1970-10-16 Made Labor Sa Un metodo de obtencion de alfa-cetoglutarato de piridoxina y sus derivados.
US3784553A (en) * 1972-01-17 1974-01-08 Made Labor Sa Pyridoxine alpha-ketoglutarate and its derivatives

Also Published As

Publication number Publication date
DE3137125A1 (de) 1982-04-01
FR2490493A1 (fr) 1982-03-26
SE8105561L (sv) 1982-03-23
ZA816242B (en) 1982-08-25
DE3137125C2 (it) 1989-04-06
CA1177408A (en) 1984-11-06
JPS5782316A (en) 1982-05-22
IT8024827A0 (it) 1980-09-22
FR2490493B1 (fr) 1986-03-07
IT1141070B (it) 1986-10-01
CH655009A5 (it) 1986-03-27
NL8104357A (nl) 1982-04-16
GB2084018A (en) 1982-04-07
BE890454A (fr) 1982-01-18
US4361570A (en) 1982-11-30

Similar Documents

Publication Publication Date Title
SE459899B (sv) Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi
US10485774B2 (en) Enterically coated cysteamine, cystamine and derivatives thereof
CN101897970A (zh) 用于治疗糖尿病的组合物和方法
US20080249168A1 (en) Pharmaceutical composition for gout
Slonim et al. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy
KR20200059274A (ko) 케톤 형성 식이 호환성 펜플루라민 제제
HILLMAN Tocopherol excess in man: Creatinuria associated with prolonged ingestion
ARTHUR MIRSKY et al. The hypoglycemic action of metabolic derivatives of L-tryptophan by mouth
McDaniel et al. Tryptophan-niacin metabolism in alloxan diabetic rats
US5491150A (en) Supplementary therpeutic agents for the treatment of immunodeficiency syndrome
Sackner et al. Severe hypoglycemia after the ingestion of a sulfonylurea compound
JPH03135918A (ja) 免疫賦活剤
CN116761601A (zh) 依达拉奉口服给药用医药组合物及其给药方法
Frost The relation of nutritional deficiencies to graying
EP0137514B1 (en) Compounds and compositions for use in preventing and treating obesity
Kercher et al. The synthesis of vitamin B12 after oral and parenteral administration of inorganic cobalt to cobalt-deficient sheep
Kurlan Dietary therapy for motor fluctuations in Parkinson's disease
JP2001048794A (ja) 桑の葉由来粉末およびカキ由来粉末の混合物を含むniddm治療用の医薬組成物および健康食品
Lloyd-Still et al. Intravenous hyperalimentation in pediatrics
WO2022061962A1 (zh) 一种l型氨基酸转运蛋白抑制剂或拮抗剂有效干预糖尿病的方法
CN1913879B (zh) 用于治疗糖尿病的组合物和制药用途
Seino et al. Effect of dietary environment on the development of impaired glucose tolerance and pancreatic hormone secretion in neonatal streptozocin-treated (NSZ) rats
Nabih et al. Structure and activity of thiazole‐type schistosomicidal agents
JPH0549646B2 (it)
JP2005015417A (ja) 抗疲労組成物

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8105561-8

Effective date: 19920408

Format of ref document f/p: F